Pharmacy

New shortages of blood pressure drugs in the U.S. are likely after a string of recent recalls linked to the discovery of a probable human carcinogen in the medications, the FDA warned Jan. 25.  

The latest round of pricing changes for generic medications could save Medicaid $126 million annually, according to data analyzed by 46brooklyn research.

A key study failed to show Eli Lilly's cancer drug Lartruvo prolonged lives. Now, the FDA is warning that the medication shouldn't be used in new patients and those already taking it should ask their physicians if they should continue,…

Walgreens shareholders preliminarily approved a plan requiring the company to explain its strategy for monitoring and managing the risks associated with the U.S. opioid crisis, according to CNBC.

AbbVie reported a net loss of $1.83 billion in the fourth quarter of 2018, down from the company's net income of $52 million in the same period last year, Investor Place reports.

Civica Rx, the nonprofit generic drug company formed by a group of hospital systems, expects to provide about 20 products this year to alleviate shortages, according to Reuters.

About 89 percent of the credit rating changes in the pharmaceutical industry in the last five years have been downgrades, according to a new report from S&P Global Ratings.  

In a major win for generic drugmakers, the U.S. Supreme Court upheld disputed language in a patent law that could make patents easier to cancel, STAT reports.

Massachusetts Gov. Charlie Barker unveiled a  plan Jan. 23 to rein in the rising cost of prescription drugs in the state by allowing direct negotiation with drugmakers and increasing state oversight of expensive medications, according to The Boston Globe.

Theravance Biopharma Inc., headquartered in South San Francisco, will cut 14 percent of its workforce in a cost-saving move as it works to launch one drug and expand other drugs into clinical trials, the San Francisco Business Times reports.